Roche breast cancer pill fails to help older women
Swiss drugmaker Roche Holding AG’s oral chemotherapy drug Xeloda,or capecitabine, proved inferior to standard chemotherapy intreating older women with early stage breast cancer, a studyreleased on Saturday at a major meeting of oncology specialistsfound.
More: continued here
